BPER Banca SpA (BIT:BPE)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-	1,403	1,519	1,449	525.12	236.93
Depreciation & Amortization	-	173.24	267.44	232.39	285.08	171.1
Other Amortization	-	123.11	-	-	-	-
Gain (Loss) on Sale of Investments	-	-93.04	-161.48	16.91	-63.92	-32.44
Total Asset Writedown	-	71.91	47.66	30.16	64.46	17.07
Provision for Credit Losses	-	421.7	530.56	750.79	1,154	664.71
Change in Trading Asset Securities	-	1,452	1,584	547.66	-329.81	465.49
Change in Other Net Operating Assets	-	-6,966	-8,106	10,380	294.46	-2,152
Other Operating Activities	-	919.28	898.44	-612.85	-664.81	-11.31
Operating Cash Flow	-	-2,495	-3,420	12,794	1,265	-640.9
Operating Cash Flow Growth	-	-	-	911.46%	-	-
Capital Expenditures	-	-135.67	-155.8	-164.06	-148.85	-143.21
Sale of Property, Plant and Equipment	-	36.68	71.28	41.56	25.05	20.62
Cash Acquisitions	-	-	-	279.23	-520.34	-
Investment in Securities	-	106.13	-3.85	-3.28	-1.6	-7.96
Purchase / Sale of Intangibles	-	-222.43	-225.72	-170.53	-97.39	-92.58
Investing Cash Flow	-	-215.29	-314.08	-17.07	-743.13	-223.13
Issuance of Common Stock	-	989.85	2.68	5.77	-	776.19
Repurchase of Common Stock	-	-28.66	-	-	-3.06	-
Common Dividends Paid	-	-423.83	-169.71	-84.67	-56.51	-
Other Financing Activities	-	-24.03	-11.35	-6.61	-4.56	-3.22
Financing Cash Flow	-	513.33	-178.37	-85.5	-64.13	772.97
Foreign Exchange Rate Adjustments	-	-0.34	0.15	-0.27	-0.46	0.42
Net Cash Flow	-	-2,198	-3,912	12,691	457.18	-90.64
Free Cash Flow	-	-2,631	-3,575	12,630	1,116	-784.11
Free Cash Flow Growth	-	-	-	1031.66%	-	-
Free Cash Flow Margin	-	-51.02%	-72.68%	348.13%	44.17%	-40.77%
Free Cash Flow Per Share	-	-1.82	-2.46	8.72	0.77	-1.10

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.